Therry Pharma SRL
1.7 FTETherry Pharma reported total assets of 185,837 € at the end of the 2025 financial year (annual accounts filed with the NBB on 15 Jul 2026), with 1.7 full-time equivalent.
The score of Therry Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets 0 % Headcount (avg FTE) -29 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Therry Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 15 Jul 2026
- Year ended 31 Dec 2024filed on 27 Aug 2025
- Year ended 31 Dec 2023filed on 26 Aug 2024
- Year ended 31 Dec 2022filed on 10 Aug 2023
- Year ended 31 Dec 2021filed on 09 Jun 2022
Therry Pharma's financial analysis
- Solvency-1.2%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Therry Pharma
Therry Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0806.638.934
- VAT number
- BE0806638934
- Peppol
- Registered · 0208:0806638934 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 26 Sep 2008
- Registered office
- 1080 Molenbeek-Saint-Jean
- Size
- Micro · 1.7 FTE
- Latest accounts
- 2025 · filed on 15 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Therry Pharma (SRL) has been based in Molenbeek-Saint-Jean since 2008, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 7,144 € and equity of −2,188 €; its revenue is not published. With 1.7 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at -1.2%, below the median of its sector (37.8%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Therry Pharma
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie YSER Retail sale of pharmaceutical products Brussels · balance sheet 808,126 €
- BERA Business and other management consultancy activities Antwerp · balance sheet 140,519 €
- CosProf Studio Business and other management consultancy activities Niel · balance sheet 120,568 €
- Swilem Pharmaceuticals Business and other management consultancy activities Evere · balance sheet 292,979 €
- Novafontis Business and other management consultancy activities Liège · balance sheet 131,719 €
- Pharmaschmidt Retail sale of pharmaceutical products Liège · balance sheet 485,219 €
- Pochet - de Waleffe Retail sale of pharmaceutical products Gembloux · balance sheet 516,803 €
- Management Consulting Pharma Retail sale of pharmaceutical products Perwez · balance sheet 155,710 €
Frequently asked questions about Therry Pharma
What is the revenue of Therry Pharma?
Therry Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Therry Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0806638934 for Therry Pharma, if the company is VAT-registered. Its company number (CBE) is 0806.638.934.
Where is the registered office of Therry Pharma?
According to the CBE register, the registered office of Therry Pharma is in 1080 Molenbeek-Saint-Jean.
What is the equity of Therry Pharma?
At the close of the 2025 financial year, the equity of Therry Pharma amounts to -2,188 €, a solvency of -1.2% of total assets.
How many people work at Therry Pharma?
1.7 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Therry Pharma?
The register lists 2 active mandates at Therry Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Therry Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →